06-08-2024 |
PM |
|
ADCT |
ADC Therapeutics SA |
253.41 |
-0.38 |
-0.42 |
-0.58 |
ADC Therapeutics reports Q2 results [8/6/2024 7:57 AM] |
2.92 |
0.05 (1.92%) |
0.0 |
0.0 (0.00%) |
0.36 - 6.04 |
460,960 |
410,000 |
0 |
|
|
06-05-2024 |
PM |
|
ADCT |
ADC Therapeutics SA |
390.36 |
-0.56 |
-0.58 |
-0.74 |
ADC Therapeutics Non-GAAP EPS of -$0.38, revenue of $17.8M misses by $0.32M [5/6/2024 6:13 AM] |
4.43 |
-0.47 (-9.59%) |
4.82 |
-0.08 (-1.63%) |
0.36 - 6.04 |
1,848,311 |
290,000 |
1,405,965 |
|
|
13-03-2024 |
PM |
|
ADCT |
ADC Therapeutics SA |
358.86 |
-1.03 |
-0.40 |
-0.30 |
ADC Therapeutics Non-GAAP EPS of -$0.97, revenue of $16.79M beats by $1.53M [3/13/2024 7:04 AM] |
3.86 |
-0.59 (-13.26%) |
4.35 |
-0.10 (-2.25%) |
0.36 - 6.04 |
1,647,800 |
560,000 |
16,870 |
|
|
07-11-2023 |
PM |
|
ADCT |
ADC Therapeutics SA |
64.51 |
-0.58 |
-0.61 |
-0.65 |
ADC Therapeutics Non-GAAP EPS of -$0.41, revenue of $14.49M misses by $0.67M [11/7/2023 7:15 AM] |
0.73 |
-0.13 (-15.41%) |
0.83 |
-0.03 (-3.82%) |
0.63 - 5.75 |
404,149 |
280,000 |
9,293 |
|
|
08-08-2023 |
PM |
|
ADCT |
ADC Therapeutics SA |
118.54 |
-0.58 |
-0.44 |
-0.84 |
ADC Therapeutics GAAP EPS of -$0.58 misses by $0.01, revenue of $19.2M misses by $22.37M [8/8/2023 7:28 AM] |
1.61 |
0.18 (12.59%) |
1.50 |
0.07 (4.90%) |
1.22 - 10.82 |
692,190 |
470,000 |
10,269 |
|
|
09-05-2023 |
PM |
7:00 AM ET (May 9) |
ADCT |
ADC Therapeutics SA |
158.06 |
-0.74 |
-0.80 |
-0.22 |
ADC Therapeutics Non-GAAP EPS of -$0.53, revenue of $18.99M misses by $1.1M [5/9/2023 7:10 AM] |
2.19 |
0.07 (3.30%) |
0.0 |
0.0 (0.00%) |
1.85 - 10.98 |
338,269 |
350,000 |
0 |
|
|
28-02-2023 |
PM |
7:00 AM ET (Feb 28) |
ADCT |
ADC Therapeutics SA |
334.67 |
-0.30 |
-0.49 |
-0.45 |
ADC Therapeutics Non-GAAP EPS of -$0.10 misses by $0.05, revenue of $19.8M misses by $45.69M [2/28/2023 7:02 AM] |
3.62 |
-0.45 (-11.06%) |
3.98 |
-0.09 (-2.21%) |
2.69 - 17.28 |
444,723 |
300,000 |
26,293 |
|
|
08-11-2022 |
PM |
7:00 AM ET (Nov 8) |
ADCT |
ADC Therapeutics SA |
339.31 |
-0.65 |
-0.51 |
-0.93 |
ADC Therapeutics Non-GAAP EPS of $0.13, revenue of $76.32M [11/8/2022 7:11 AM] |
4.16 |
-0.10 (-2.35%) |
4.60 |
0.34 (7.98%) |
4.00 - 29.74 |
443,688 |
340,000 |
22,666 |
|
|
09-08-2022 |
PM |
7:00 AM ET (Aug 9) |
ADCT |
ADC Therapeutics SA |
565.33 |
-0.84 |
-0.96 |
-0.95 |
ADC Therapeutics Non-GAAP EPS of -$0.73, revenue of $17.29M misses by $13.93M [8/9/2022 7:10 AM] |
7.94 |
-0.11 (-1.37%) |
8.05 |
0.0 (0.00%) |
5.52 - 32.00 |
196,378 |
280,000 |
391 |
|
|
09-05-2022 |
PM |
7:00 AM ET (May 9) |
ADCT |
ADC Therapeutics SA |
869.49 |
-0.22 |
-0.76 |
-0.67 |
ADC Therapeutics Non-GAAP EPS of -$0.36, revenue of $46.5M beats by $12.57M [5/9/2022 7:10 AM] |
7.46 |
-3.49 (-31.87%) |
10.95 |
0.0 (0.00%) |
7.41 - 32.00 |
655,749 |
150,000 |
203 |
|
|
03-03-2022 |
PM |
7:00 AM ET (Mar 3) |
ADCT |
ADC Therapeutics SA |
1,280 |
-0.45 |
-0.87 |
-0.73 |
ADC Therapeutics Non-GAAP EPS of -$0.39 beats by $0.49, revenue of $17.01M beats by $0.54M [3/3/2022 7:11 AM] |
15.00 |
-1.22 (-7.52%) |
17.03 |
0.81 (4.99%) |
13.34 - 32.00 |
177,066 |
140,000 |
400 |
|
|
02-11-2021 |
PM |
7:00 AM ET (Nov 2) |
ADCT |
ADC Therapeutics SA |
2,250 |
-0.93 |
-0.97 |
-0.29 |
ADC Therapeutics EPS misses by $0.01, beats on revenue [11/2/2021 7:14 AM] |
29.18 |
-2.33 (-7.39%) |
32.50 |
0.99 (3.14%) |
20.01 - 38.34 |
774,913 |
160,000 |
1,140 |
|
|
03-08-2021 |
PM |
7:00 AM ET (Aug 3) |
ADCT |
ADC Therapeutics SA |
1,650 |
-0.95 |
-0.84 |
-0.71 |
ADC Therapeutics EPS misses by $0.09, beats on revenue [8/3/2021 7:08 AM] |
22.72 |
2.01 (9.68%) |
21.50 |
0.79 (3.81%) |
20.01 - 53.35 |
395,333 |
220,000 |
141 |
|
|
06-05-2021 |
PM |
7:00 AM ET (May 6) |
ADCT |
ADC Therapeutics SA |
1,730 |
-0.67 |
1.00 |
0.00 |
ADC Therapeutics EPS beats by $0.17 [5/6/2021 7:04 AM] |
22.61 |
0.61 (2.77%) |
22.61 |
0.0 (0.00%) |
21.16 - 56.59 |
417,185 |
540,000 |
3,038 |
|
|
18-03-2021 |
PM |
7:00 AM ET (Mar 18) |
ADCT |
ADC Therapeutics SA |
1,920 |
-0.73 |
-0.68 |
0.00 |
ADC Therapeutics reports Q4 results [3/18/2021 7:09 AM] |
28.99 |
-0.41 (-1.39%) |
29.95 |
0.55 (1.87%) |
21.51 - 56.59 |
572,910 |
510,000 |
4,166 |
|
|
12-11-2020 |
PM |
7:15 AM ET (Nov 12) |
ADCT |
ADC Therapeutics SA |
2,510 |
-0.29 |
-0.77 |
0.00 |
ADC Therapeutics reports Q3 results [11/12/2020 7:11 AM] |
34.00 |
-0.67 (-1.93%) |
0.0 |
0.0 (0.00%) |
25.10 - 56.59 |
143,002 |
155,723 |
0 |
|
|
18-08-2020 |
PM |
Before the open (Aug 18) |
ADCT |
ADC Therapeutics SA |
2,800 |
-0.71 |
-0.76 |
0.00 |
|
39.00 |
0.38 (0.98%) |
0.0 |
0.0 (0.00%) |
28.50 - 56.59 |
129,400 |
223,715 |
0 |
|
|